Gallbladder cancer epidemiology, treatment and survival in Southern Finland – a population-based study

References

• World Health Organization. Cancer WIAfRo. global cancer observatory: cancer today. 2018 [cited 2019 Jun 26]. Available from: http://gco.iarc.fr/
   Google Scholar
• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68:394–424.
   PubMed Web of Science ®Google Scholar
• Henley SJ, Weir HK, Jim MA, et al. Gallbladder cancer incidence and mortality, United States 1999-2011. Cancer Epidemiol Biomarkers Prev. 2015; 24:1319–1326.
   PubMed Web of Science ®Google Scholar
• Jaruvongvanich V, Yang JD, Peeraphatdit T, et al. The incidence rates and survival of gallbladder cancer in the USA. Eur J Cancer Prev. 2019; 28:1–9.
   PubMed Web of Science ®Google Scholar
• Rahman R, Simoes EJ, Schmaltz C, et al. Trend analysis and survival of primary gallbladder cancer in the United States: A 1973-2009 population-based study. Cancer Med. 2017; 6:874–880.
   PubMed Web of Science ®Google Scholar
• Malhotra RK, Manoharan N, Shukla NK, et al. Gallbladder cancer incidence in Delhi urban: A 25-year trend analysis. Indian J Cancer. 2017; 54:673–677.
   PubMed Web of Science ®Google Scholar
• Kilander C, Lagergren J, Ljung R, et al. The population-based incidence and mortality of biliary tract cancer in Sweden. Cancer Epidemiol. 2018; 56:14–20.
   PubMed Web of Science ®Google Scholar
• Bjerregaard JK, Mortensen MB, Pfeiffer P, Academy of Geriatric Cancer Research (AgeCare). Trends in cancer of the liver, gall bladder, bile duct, and pancreas in elderly in denmark, 1980-2012. Acta Oncol. 2016; 55 Suppl 1:40–45.
   PubMed Web of Science ®Google Scholar
• Torre LA, Siegel RL, Islami F, et al. Worldwide burden of and trends in mortality from gallbladder and other biliary tract cancers. Clin Gastroenterol Hepatol. 2018; 16:427–437.
   PubMed Web of Science ®Google Scholar
• Murphy BL, Ubl DS, Zhang J, et al. Trends of inguinal hernia repairs performed for recurrence in the United States. Surgery. 2018;163:343–350.
   PubMed Web of Science ®Google Scholar
• Bergquist JR, Shah HN, Habermann EB, et al. Adjuvant systemic therapy after resection of node positive gallbladder cancer: time for a well-designed trial? (Results of a US-national retrospective cohort study). Int J Surg. 2018; 52:171–179.
   PubMed Web of Science ®Google Scholar
• Hickman L, Contreras C. Gallbladder cancer: diagnosis, surgical management, and adjuvant therapies. Surg Clin North Am. 2019; 99:337–355.
   PubMed Web of Science ®Google Scholar
• Primrose JN, Fox RP, Palmer DH, et al., BILCAP study group. Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study. Lancet Oncol. 2019;20:663–673.
   PubMed Web of Science ®Google Scholar
• Agrawal S, Mohan L, Mourya C, et al. Radiological downstaging with neoadjuvant therapy in unresectable gall bladder cancer cases. Asian Pac J Cancer Prev. 2016; 17:2137–2140.
   PubMedGoogle Scholar
• Creasy JM, Goldman DA, Dudeja V, et al. Systemic chemotherapy combined with resection for locally advanced gallbladder carcinoma: surgical and survival outcomes. J Am Coll Surg. 2017; 224:906–916.
   PubMed Web of Science ®Google Scholar
• Chaudhari VA, Ostwal V, Patkar S, et al. Outcome of neoadjuvant chemotherapy in “locally advanced/borderline resectable” gallbladder cancer: the need to define indications. HPB. 2018; 20:841–847.
   PubMed Web of Science ®Google Scholar
• Hakeem AR, Papulas M, Menon KV. The role of neoadjuvant chemotherapy or chemoradiotherapy for advanced gallbladder cancer - a systematic review. Eur J Oncol Surg. 2019;45:83–91.
   PubMed Web of Science ®Google Scholar
• Lee SE, Kim KS, Kim WB, et al., Korean Association of Hepato-Biliary and Pancreas Surgery. Practical guidelines for the surgical treatment of gallbladder cancer. J Korean Med Sci. 2014;29:1333–1340.
   PubMed Web of Science ®Google Scholar
• Benson AB, D'Angelica MI, Abbot DE, et al. NCCN clinical practice guidelines in oncology: hepatobiliary cancers. Version 5. 2020. Available from: https://www.nccn.org/professionals/physician_gls/pdf/hepatobiliary_blocks.pdf
   Google Scholar
• Shindoh J, de Aretxabala X, Aloia TA, et al. Tumor location is a strong predictor of tumor progression and survival in T2 gallbladder cancer: an international multicenter study. Ann Surg. 2015; 261:733–739.
   PubMed Web of Science ®Google Scholar
• Lee H, Choi DW, Park JY, et al. Surgical strategy for T2 gallbladder cancer according to tumor location. Ann Surg Oncol. 2015; 22:2779–2786.
   PubMed Web of Science ®Google Scholar
• Lee SE, Jang JY, Lim CS, et al. Systematic review on the surgical treatment for T1 gallbladder cancer. World J Gastroenterol. 2011;17:174–180.
   PubMed Web of Science ®Google Scholar
• Aloia TA, Jarufe N, Javle M, et al. Gallbladder cancer: expert consensus statement. HPB. 2015;17:681–690.
   PubMed Web of Science ®Google Scholar
• Nigri G, Berardi G, Mattana C, et al. Routine extra-hepatic bile duct resection in gallbladder cancer patients without bile duct infiltration: a systematic review. Surgeon. 2016; 14:337–344.
   PubMed Web of Science ®Google Scholar
• Ethun CG, Postlewait LM, Le N, et al. Routine port-site excision in incidentally discovered gallbladder cancer is not associated with improved survival: a multi-institution analysis from the US extrahepatic biliary malignancy consortium. J Surg Oncol. 2017; 115:805–811.
   PubMed Web of Science ®Google Scholar
• Fuks D, Regimbeau JM, Le Treut YP, et al. Incidental gallbladder cancer by the AFC-GBC-2009 study group. World J Surg. 2011; 35:1887–1897.
   PubMed Web of Science ®Google Scholar
• Fuks D, Regimbeau JM, Pessaux P, et al. Is port-site resection necessary in the surgical management of gallbladder cancer? J Visc Surg. 2013; 150:277–284.
   PubMed Web of Science ®Google Scholar
• Witjes CD, van den Akker SA, Visser O, et al. Gallbladder cancer in the netherlands: incidence, treatment and survival patterns since 1989. Dig Surg. 2012; 29:92–98.
   PubMed Web of Science ®Google Scholar
• Lindner P, Holmberg E, Hafstrom L. Gallbladder cancer - no improvement in survival over time in a Swedish population. Acta Oncol. 2018; 57:1482–1489.
   PubMed Web of Science ®Google Scholar
• de Savornin Lohman E, de Bitter T, Verhoeven R, et al. Trends in treatment and survival of gallbladder cancer in the Netherlands; identifying gaps and opportunities from a nation-wide cohort. Cancers. 2020;12:918.
   PubMed Web of Science ®Google Scholar
• Leinonen MK, Miettinen J, Heikkinen S, et al. Quality measures of the population-based Finnish cancer registry indicate sound data quality for solid malignant tumours. Eur J Cancer. 2017; 77:31–39.
   PubMed Web of Science ®Google Scholar
• Finnish National Institute of Health and Welfare. Somatic health care 2018. Database report 51/2019 [cited 2019 Dec 19]. Available from: http://www.julkari.fi/handle/10024/139004
   Google Scholar
• Danckert B, Ferlay J, Engholm G, et al. NORDCAN: cancer incidence, mortality and survival in the nordic countries, Version 8.2. 2019 Mar 26 [cited 2020 Jun 30].
   Google Scholar
• R Core Team. R: a language and environment for statistical computing. Vol. 2019. Vienna (Austria): R foundation for statistical computing; 2017. Available from: https://www.R-project.org/
   Google Scholar
• Randi G, Franceschi S, La Vecchia C. Gallbladder cancer worldwide: geographical distribution and risk factors. Int J Cancer. 2006; 118:1591–1602.
   PubMed Web of Science ®Google Scholar
• Finnish National Institute of Health and Welfare. Annual number of operations. Database report. 2019 [cited 2021 Feb 20]. Available from: https://sampo.thl.fi/pivot/prod/fi/thil
   Google Scholar
• World Health Organization. Nutrition, physical activity and obesity. Finland; [cited 2021 Feb 26]. Available from: https://www.euro.who.int/__data/assets/pdf_file/0008/243296/Finland-WHO-Country-Profile.pdf
   Google Scholar
• Akhtar-Danesh N, Akhtar-Danseh GG, Seow H, et al. Treatment modality and trends in survival for gallbladder cancer: a population-based study. J Gastrointest Cancer. 2021; 52:256–262.
   PubMed Web of Science ®Google Scholar
• Valle JW, Borbath I, Khan SA, et al., ESMO Guidelines Committee. Biliary cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2016;27:v28–v37.
   PubMed Web of Science ®Google Scholar
• Shroff RT, Kennedy EB, Bachini M, et al. Adjuvant therapy for resected biliary tract cancer: ASCO clinical practice guideline. J Clin Oncol. 2019; 37:1015–1027.
   PubMed Web of Science ®Google Scholar
• Kilander C, Mattsson F, Ljung R, et al. Systematic underreporting of the population-based incidence of pancreatic and biliary tract cancers. Acta Oncol. 2014; 53:822–829.
   PubMed Web of Science ®Google Scholar